Skip to content
Clinical Trials – home
BelgiumBack to Belgium

Clinical trials in Turnhout – page 2

33 clinical trials in Turnhout, Belgium. Every trial is listed in the EU Clinical Trials Register and updated daily.

Turnhout at a glance
33
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

33 trials in Turnhout

Open in trial search

Study of Semaglutide for Treating Prediabetes in Women with Previous Gestational Diabetes

Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years
  • Substances:Semaglutide
  • Sponsor:UZ Leuven

Arteriosclerosis

Not yet recruiting

Study of olpasiran to prevent first major cardiovascular events in people with high levels of lipoprotein(a)

Investigational
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Sponsor:Amgen Inc.

Endometrial cancer

Not yet recruiting

Study of GSK5733584 versus paclitaxel or doxorubicin in patients with advanced or recurrent endometrial cancer after platinum‑based chemotherapy and immunotherapy

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:GSK5733584
  • Sponsor:Glaxosmithkline Research & Development Limited

A Study of Ponsegromab Combined with Chemotherapy for Adults with Pancreatic Cancer that has Spread and Caused Weight Loss

Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Ponsegromab
  • Sponsor:Pfizer Inc.

Arteriosclerosis

Not recruiting

A study to evaluate the effect of olpasiran on major cardiovascular events in patients with atherosclerotic cardiovascular disease and high levels of lipoprotein(a)

Investigational
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Sponsor:Amgen Inc.

Chronic hepatitis B

Not recruiting

Study on Stopping Tenofovir Alafenamide, Tenofovir Disoproxil, and Entecavir in Patients with Chronic Hepatitis B

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Entecavir
  • Sponsor:Antwerp University Hospital

Breast cancer+1

Not recruiting

Study of PF-07220060 and Fulvestrant for Adults with Advanced or Metastatic HR-positive, HER2-negative Breast Cancer After Previous Treatment

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Everolimus
  • Sponsor:Pfizer Inc.

Study Comparing XL092 and Atezolizumab with Regorafenib for Patients with Metastatic Colorectal Cancer

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:Exelixis Inc.
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Anakinra
  • Sponsor:Genmab A/S

Gastric cancer

Not recruiting

Study of Bemarituzumab with Chemotherapy and Nivolumab in Untreated Advanced Gastric and Gastroesophageal Junction Cancer Patients with FGFR2b Overexpression

Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Bemarituzumab
  • Sponsor:Amgen Inc.

Study on Nitric Oxide and Saline Nasal Sprays for Treating COVID-19 and Similar Illnesses in Primary Care Patients

Investigational
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Nitric Oxide
  • Sponsor:Universitair Medisch Centrum Utrecht

Study on the Safety and Effectiveness of Epcoritamab with Rituximab and Lenalidomide for Patients with Relapsed or Refractory Follicular Lymphoma

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Epcoritamab
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Other cities in Belgium

The busiest research cities in the country

All 170 cities in Belgium

Clinical research in Turnhout

What the registry says about research in the country

01 Oncology Research

Groundbreaking trials focusing on breast cancer, colorectal cancer, and prostate cancer treatments. Studies include evaluation of novel therapies and treatment combinations for both early-stage and metastatic diseases.

  • Advanced breast cancer therapies
  • Colorectal cancer interventions
  • Prostate cancer treatment optimization

Multiple trials exploring targeted therapies and combination treatments to improve patient outcomes.

02 Cardiovascular Studies

Comprehensive research addressing coronary artery disease and atrial fibrillation. Studies evaluate new antiplatelet therapies and innovative stent technologies.

  • Antiplatelet therapy optimization
  • Coronary stent evaluations
  • Post-heart attack treatments

Investigations into both interventional procedures and medical management strategies.

03 Gastrointestinal Research

Studies focusing on Crohn's disease management and chronic conditions. Research includes evaluation of long-term treatment efficacy and novel therapeutic approaches.

  • Inflammatory bowel disease treatments
  • Hepatitis B management
  • Gastric medication optimization

Innovative approaches to treating chronic gastrointestinal conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.